Zobrazeno 1 - 10
of 23 179
pro vyhledávání: '"G. Fraser"'
Autor:
Terry Walsh
Publikováno v:
The Journal of Classics Teaching, Vol 25, Pp 86-87 (2024)
Externí odkaz:
https://doaj.org/article/db78f525bda8441699377b8062e9f8c9
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Purpose Chimeric antigen receptor T-cell (CART) therapy has shown clinical efficacy in refractory and relapsed large B-cell lymphomas, but is associated with serious acute and long-term toxicities. To understand the patient perspective, we m
Externí odkaz:
https://doaj.org/article/d698902dbf064ab5803aeb8e9a30c975
Autor:
Ibrahim, Ahmed H.
Publikováno v:
International Journal of Middle East Studies, 1996 Nov 01. 28(4), 624-627.
Externí odkaz:
https://www.jstor.org/stable/176176
Autor:
Buckley, Roger
Publikováno v:
The SHAFR Guide Online
Externí odkaz:
https://doi.org/10.1163/2468-1733_shafr_SIM140160163
Autor:
Lowe, Peter
Publikováno v:
The SHAFR Guide Online
Externí odkaz:
https://doi.org/10.1163/2468-1733_shafr_SIM140160047
Autor:
Taylor Davie, Xènia Serrat, Lea Imhof, Jamie Snider, Igor Štagljar, Jennifer Keiser, Hiroyuki Hirano, Nobumoto Watanabe, Hiroyuki Osada, Andrew G. Fraser
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Soil-transmitted helminths (STHs) are major pathogens infecting over a billion people. There are few classes of anthelmintics and there is an urgent need for new drugs. Many STHs use an unusual form of anaerobic metabolism to survive the hyp
Externí odkaz:
https://doaj.org/article/7b162390c2ff406b8a23937a897ef68f
Autor:
Shepherd, Francis G. G.
Publikováno v:
BMJ: British Medical Journal, 1991 Aug 01. 303(6798), 359-359.
Externí odkaz:
https://www.jstor.org/stable/29712623
Publikováno v:
The British Medical Journal, 1920 Oct 01. 2(3118), 532-532.
Externí odkaz:
https://www.jstor.org/stable/20425355
Publikováno v:
The British Medical Journal, 1922 Nov 01. 2(3227), 896-896.
Externí odkaz:
https://www.jstor.org/stable/20421583
Autor:
Lotje A. Hoogervorst, Timon H. Geurkink, Anne Lübbeke, Sergio Buccheri, Jan W. Schoones, Marina Torre, Paola Laricchiuta, Paul Piscoi, Alma B. Pedersen, Chris P. Gale, James A. Smith, Aldo P. Maggioni, Stefan James, Alan G. Fraser, Rob G.H.H. Nelissen, Perla J. Marang-van de Mheen
Publikováno v:
International Journal of Health Policy and Management, Vol 12, Iss Issue 1, Pp 1-11 (2023)
Background The European Union Medical Device Regulation (MDR) requires manufacturers to undertake post-market clinical follow-up (PMCF) to assess the safety and performance of their devices following approval and Conformité Européenne (CE) marking.
Externí odkaz:
https://doaj.org/article/220a8f13eb7642cc94ecf2784168d74c